Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth

被引:90
|
作者
Sid, B
Sartelet, H
Bellon, G
El Btaouri, H
Rath, G
Delorme, N
Haye, B
Martiny, L
机构
[1] CNRS, Biochim Lab, UFR Sci Reims, FRE 2534,IFR 53 Biomol, F-51687 Reims 2, France
[2] Univ Reims, Biochim Lab, UFR Med, FRE 2534,CNRS,IFR 53 Biomol, F-51095 Reims, France
关键词
thrombospondin; 1; tumor growth; invasion; matrix metalloproteinases; apoptosis; internalization;
D O I
10.1016/j.critrevonc.2003.09.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thrombospondins belong to a family of extracellular matrix (ECM) proteins widely found-from embryonic to adult tissues. The modular structure of thrombospondins contains a sefies of peptide sequences implicated in a multiplicity of biological functions. Extracellular matrix undergoes important alterations under proteolysis that occurs in pathological processes like tumorigenesis. An elevated secretion of thrombospondin 1 (TSP1) is often observed in tumors and is sometimes considered as a predictive factor. However, the role of TSP1 in cancer progression remains controversial and must be carefully apprehended. The regulation of cell adhesion, proliferation, apoptosis by TSP1 is examined in the present review and it is clear from the literature and from our investigations that TSP1 presents both stimulatory and inhibitory effects. The exposition of cryptic sites upon conformational changes can partially explain this contradiction. More interestingly, the analysis of TSP1-directed intracellular signaling pathways activated through specific receptors or supramolecular receptors docking systems may be useful to discriminate the precise function of TSP1 in tumor progression. The central role played by TSP1 in the control of matrix-degrading enzyme activation and catabolism reveals attractive tracks of research and highlights the involvement of the lipoprotein receptor-related protein (LRP) receptor in these events. Therefore, TSP1-derived peptides constitute a source of potentially active matrikins which could provide essential tools in cancer therapy. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:245 / 258
页数:14
相关论文
共 50 条
  • [41] The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature
    Pinessi, Denise
    Resovi, Andrea
    Morosi, Lavinia
    Borsotti, Patrizia
    Berndt, Alexander
    Giavazzi, Raffaella
    Zucchetti, Massimo
    Taraboletti, Giulia
    CANCER RESEARCH, 2019, 79 (13)
  • [42] The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature
    Pinessi, D.
    Resovi, A.
    Morosi, L.
    Borsotti, P.
    Berndt, A.
    Giavazzi, R.
    Zucchetti, M.
    Taraboletti, G.
    THROMBOSIS RESEARCH, 2021, 200 : S58 - S59
  • [43] Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma
    Lin, Xian-Dong
    Chen, Shu-Qin
    Qi, Yuan-Lin
    Zhu, Jin-Wei
    Tang, Yang
    Lin, Jian-Yin
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (01) : 94 - 100
  • [44] Overexpression of thrombospondin-1 inhibits bladder tumor growth: A novel therapy for invasive bladder cancer
    Bochner, BH
    Windham, CQ
    Pao, MM
    Kasahara, N
    Skinner, DG
    Jones, PA
    JOURNAL OF UROLOGY, 1998, 159 (05): : 282 - 282
  • [45] Quantitative regulation of gene expression of human endothelial tumor markers by thrombospondin-1 and nitric oxide crosstalk
    Li, Dayan
    Isenberg, Jeff S.
    Pendrak, Michael L.
    Roberts, David D.
    FASEB JOURNAL, 2008, 22
  • [46] Thrombospondin and growth regulation in human vascular smooth muscle cells.
    Schachter, M
    Sawhney, N
    Refson, JS
    Hughes, AD
    Sever, PS
    HYPERTENSION, 1996, 28 (04) : 704 - 704
  • [47] Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
    Streit, M
    Riccardi, L
    Velasco, P
    Brown, LF
    Hawighorst, T
    Bornstein, P
    Detmar, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 14888 - 14893
  • [48] SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to Antiangiogenic thrombospondin-1 and slows tumor vascularization and growth
    Filleur, S
    Courtin, A
    Ait-Si-Ali, S
    Guglielmi, J
    Merle, C
    Harel-Bellan, A
    Clézardin, P
    Cabon, F
    CANCER RESEARCH, 2003, 63 (14) : 3919 - 3922
  • [49] Thrombospondin-1 acts as a host defence protein
    Niemann, S.
    Bertling, A.
    Spehr, N.
    Brodde, M. F.
    Robenek, H.
    Jurk, K.
    von Eiff, C.
    Uekoetter, A.
    Peters, G.
    Heilmann, C.
    Kehrel, B. E.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 38 - 38
  • [50] Protein engineering and properties of human metalloproteinase and thrombospondin 1
    Wei, P
    Zhao, YG
    Zhuang, L
    Hurst, DR
    Ruben, S
    Sang, QXA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (01) : 478 - 488